Cargando…
Effect of pulmonary artery pressure‐guided therapy on heart failure readmission in a nationally representative cohort
AIMS: Pulmonary artery pressure (PAP)‐guided therapy in patients with heart failure (HF) using the CardioMEMS (CMM) device, an implantable PAP sensor, has been shown to reduce HF hospitalizations in previous studies. We sought to evaluate the clinical benefit of the CMM device in regard to 30, 90, a...
Autores principales: | Kishino, Yoshikazu, Kuno, Toshiki, Malik, Aaqib H., Lanier, Gregg M., Sims, Daniel B., Ruiz Duque, Ernesto, Briasoulis, Alexandros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288808/ https://www.ncbi.nlm.nih.gov/pubmed/35560987 http://dx.doi.org/10.1002/ehf2.13956 |
Ejemplares similares
-
Effects of Clinical Trial or Research Program Participation Status on In‐Hospital Mortality After Transcatheter Aortic Valve Implantation
por: Aikawa, Tadao, et al.
Publicado: (2022) -
Heart failure with preserved ejection fraction in the elderly: pathophysiology, diagnostic and therapeutic approach
por: Duque, Ernesto Ruiz, et al.
Publicado: (2019) -
Effect of remdesivir on patients with COVID-19: A network meta-analysis of randomized control trials
por: Yokoyama, Yujiro, et al.
Publicado: (2020) -
COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis
por: Isath, Ameesh, et al.
Publicado: (2023) -
The role of renin-angiotensin system in patients with left ventricular assist devices
por: Briasoulis, Alexandros, et al.
Publicado: (2020)